Penumbra’s Neurovascular Expansion Amid Insider Sale Sparks Investor Curiosity
Penumbra Inc. (PEN) balances a promising neuro‑vascular expansion pitch at Piper Sandler with a surprising insider sell‑off, prompting investors to weigh growth prospects against potential risks.
3 minutes to read